Evidence map›Paper›PMID 27796775›Full record

Trial reportTranslational behavioral medicine2017

The healthy living partnerships to prevent diabetes and the diabetes prevention program: a comparison of year 1 and 2 intervention results.

Mara Z Vitolins, Scott P Isom, Caroline S Blackwell, Donna Kernodle, Joyce M Sydell, Carolyn F Pedley, Jeffrey A Katula, L Douglas Case, David C Goff

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Translational behavioral medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00631345 (Translating Research Into the Prevention of Diabetes Mellitus), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00631345 nacompletednot on this map

Translating Research Into the Prevention of Diabetes Mellitus (TRIP DM)

TypeinterventionalSponsorWake Forest University Health SciencesRan2007 to 2015Enrolled301ConditionsPrediabetes, ObesityArmsGroup-Based Lifestyle Intervention (Phases 1 and 2), Individual Education Program (All Phases), Self-Directed Maintenance (Phase 3), Extended Group Maintenance (Phase 3)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Drug Therapies for Diabetes.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mara Z VitolinsDivision of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. mvitolin@wakehealth.edu.
Scott P IsomDivision of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
Caroline S BlackwellDivision of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
Donna KernodleWake Forest Baptist Medical Center, Joslin Diabetes Center, Winston-Salem, NC, USA.
Joyce M SydellWake Forest Baptist Medical Center, Joslin Diabetes Center, Winston-Salem, NC, USA.
Carolyn F PedleyDepartment of Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Jeffrey A KatulaDepartment of Health & Exercise Science, Wake Forest University, Winston-Salem, NC, USA.
L Douglas CaseDivision of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
David C GoffDivision of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA.

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Translating Research into Prevention of Diabetes (TRIP Diabetes)R18DK069901 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KATULA, JEFFREY A., VITOLINS, MARA Z · 2006 to 2014
$6.1M
CDC HHSNCATS NIH HHS UL1 TR001420NIDDK NIH HHS R18 DK069901
6 · The paper itself

Abstract

A number of research studies have attempted to translate the behavioral lifestyle intervention delivered in the Diabetes Prevention Program (DPP). To compare the active interventions of two trials, Diabetes Prevention Program DPP and Healthy Living Partnerships to Prevent Diabetes (HELP PD), after 1 and 2 years of intervention. DPP included 3234 adults with prediabetes randomized to intensive lifestyle intervention, metformin, troglitazone, or placebo. The lifestyle intervention, professionally delivered to individuals in a clinical setting, focused on diet and increased physical activity. HELP PD, a community-based translation of DPP, included 301 adults randomized to receive intensive lifestyle intervention or enhanced usual care. Mean weight-losses at 1 year (6.9 kg in DPP, 6.4 kg in HELP PD) and 2 years (5.5 kg in DPP, 4.4 kg in HELP PD) were similar across studies. Reductions in glucose were also similar across studies at both time points (5.2 mg/dL in DPP and 4.1 mg/dL in HELP PD at 1 year; 1.8 mg/dL and 1.6 mg/dL at 2 years). HELP PD participants achieved larger reductions in triglycerides at 1 and 2 years (38.4 mg/dL and 34.9 mg/dL, respectively) than DPP participants (24.8 mg/dL and 22.4 mg/dL). High-density lipoprotein decreased in HELP PD participants at year 1 (-0.6 mg/dL) and increased in DPP (1.2 mg/dL) but there were no significant differences in year 2. HELP PD, a community model for diabetes prevention, was similar to DPP in reducing body weight and lowering blood glucose, both important risk factors that should be controlled to reduce risk for developing type 2 diabetes.

Indexed as

Health PromotionHealthy LifestyleBiomarkersBlood GlucoseDiabetes Mellitus, Type 2FemaleFollow-Up StudiesHumansLogistic ModelsMaleMiddle AgedTime FactorsTreatment OutcomeWeight LossBiomarkersBlood GlucoseBehavioral lifestyle interventionDiabetes preventionTranslation research

Identifiers

PMID27796775
PMCPMC5526803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.